Strategies for intranasal delivery of vaccines (Q36514771)

14 August 2017

1 reference

title

Strategies for intranasal delivery of vaccines (English)

1 reference

14 August 2017

Mehfuz Zaman

1

1 reference

PMCID

3539070

14 August 2017

Saranya Chandrudu

series ordinal

2

1 reference

PMCID

3539070

14 August 2017

Istvan Toth

series ordinal

3

1 reference

14 August 2017

12 July 2012

1 reference

Drug delivery and translational research

14 August 2017

1 reference

14 August 2017

3

1 reference

14 August 2017

100-109

1 reference

14 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s13346-012-0085-z

14 August 2017

0 references

cites work

Novel vaccine development strategies for inducing mucosal immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Immunological evaluation of lipopeptide group A streptococcus (GAS) vaccine: structure-activity relationship

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Qualitative analysis of controlled release ciprofloxacin/carbopol 934 mucoadhesive suspension

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Intranasal delivery of cationic PLGA nano/microparticles-loaded FMDV DNA vaccine encoding IL-6 elicited protective immunity against FMDV challenge

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

A step-by-step approach to study the influence of N-acetylation on the adjuvanticity of N,N,N-trimethyl chitosan (TMC) in an intranasal nanoparticulate influenza virus vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Regulation of the polymeric immunoglobulin receptor and IgA transport: new advances in environmental factors that stimulate pIgR expression and its role in mucosal immunity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Chitosan nanoparticles act as an adjuvant to promote both Th1 and Th2 immune responses induced by ovalbumin in mice

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Liposomal vaccine delivery systems

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Epithelial barrier and antigen uptake in lymphoepithelium of human adenoids

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

30 September 2017

Nasal vaccine innovation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Intranasal DNA vaccination induces potent mucosal and systemic immune responses and cross-protective immunity against influenza viruses.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Liposomes as delivery systems for nasal vaccination: strategies and outcomes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Mucosal delivery of vaccines: role of mucoadhesive/biodegradable polymers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Structure-activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Achieving polio eradication: a review of health communication evidence and lessons learned in India and Pakistan

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challenge

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Pharmaceutical aspects of intranasal delivery of vaccines using particulate systems

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

M-cells: origin, morphology and role in mucosal immunity and microbial pathogenesis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Solid lipid nanoparticles as a drug delivery system for peptides and proteins

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Normal structure, function, and histology of mucosa-associated lymphoid tissue

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Mucosal vaccines: the promise and the challenge

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Mucosal immunity and vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Preventing transmission: plant-derived microbicides and mucosal vaccines for reproductive health

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

ISCOMATRIX adjuvant for antigen delivery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Alternative routes of mucosal immunization in large animals

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Mucoadhesive interactions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

The viral sigma1 protein and glycoconjugates containing alpha2-3-linked sialic acid are involved in type 1 reovirus adherence to M cell apical surfaces

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Nasal drug delivery--possibilities, problems and solutions

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Antigen delivery to mucosa-associated lymphoid tissues using liposomes as a carrier

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Taking toll: lipid A mimetics as adjuvants and immunomodulators

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Evaluation of events occurring at mucosal surfaces: techniques used to collect and analyze mucosal secretions and cells

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Intranasal administration of a synthetic lipopeptide without adjuvant induces systemic immune responses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

The effect of chitosan and other polycations on tight junction permeability in the human intestinal Caco-2 cell line(1).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Chitosan as a novel nasal delivery system for vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

M cell-targeted DNA vaccination

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

In vitro evaluation of microparticles and polymer gels for use as nasal platforms for protein delivery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Smallpox: gone but not forgotten

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Nasal delivery of vaccines

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

New strategies for using mucosal vaccination to achieve more effective immunization

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Synthetic lipopeptides as novel adjuvants

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Immune functions of nasopharyngeal lymphoid tissue.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Design of three-component vaccines against group A streptococcal infections: importance of spatial arrangement of vaccine components.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Bacterial lipopeptides constitute efficient novel immunogens and adjuvants in parenteral and oral immunization

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3539070

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen

28 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Calorimetric studies of the interaction between sodium alginate and sodium dodecyl sulfate in dilute solutions at different pH values

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Induction of systemic and mucosal immune response in cattle by intranasal administration of pig serum albumin in alginate microparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Spray-dried powders of starch and crosslinked poly(acrylic acid) as carriers for nasal delivery of inactivated influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Characterization of chitosan hydrochloride--mucin rheological interaction: influence of polymer concentration and polymer:mucin weight ratio.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Uptake of microparticles into the epithelium of human nasopharyngeal lymphoid tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

A mucosal vaccine against diphtheria: formulation of cross reacting material (CRM(197)) of diphtheria toxin with chitosan enhances local and systemic antibody and Th2 responses following nasal delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Chitosan formulations improve the immunogenicity of a GnRH-I peptide-based vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Nasal vaccination with N-trimethyl chitosan and PLGA based nanoparticles: nanoparticle characteristics determine quality and strength of the antibody response in mice against the encapsulated antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Intranasal delivery of chitosan-DNA vaccine generates mucosal SIgA and anti-CVB3 protection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Mucosal adjuvant activity of oligomannose-coated liposomes for nasal immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Nasal immunization studies by cationic, fusogenic and cationic-fusogenic liposomes encapsulated with tetanus toxoid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Vaccination with recombinant alphavirus or immune-stimulating complex antigen against respiratory syncytial virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Evaluation of ISCOM vaccines for mucosal immunization against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Influenza virosomes are an efficient delivery system for respiratory syncytial virus-F antigen inducing humoral and cell-mediated immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Bacterial cell wall components as immunomodulators--I. Lipopeptides as adjuvants for parenteral and oral immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Lipopeptide adjuvants: monitoring and comparison of P3CSK4- and LPS-induced gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

A palmitoyl-tailed sequential oligopeptide carrier for engineering immunogenic conjugates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Expression of maturation markers on murine dendritic cells in response to group A streptococcal lipopeptide vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Intranasal lipopeptide primes lung-resident memory CD8+ T cells for long-term pulmonary protection against influenza.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Adjuvant synergy: the effects of nasal coadministration of adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Efficient delivery of DNA to dendritic cells mediated by influenza virosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

Intranasal Vaccination with a Lipopeptide Containing a Conformationally Constrained Conserved Minimal Peptide, a Universal T Cell Epitope, and a Self‐Adjuvanting Lipid Protects Mice from Group A Streptococcus Challenge and Reduces Throat Colonizati

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0085-Z

A new and versatile virosomal antigen delivery system to induce cellular and humoral immune responses

21 January 2018

1 reference

12 December 2020

Characterization of rheological and mucoadhesive properties of three grades of chitosan hydrochloride

1 reference

12 December 2020

Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers

1 reference

12 December 2020

The old Edward Jenner and the new public health: the future of vaccines in Europe

1 reference

12 December 2020

Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx

1 reference

12 December 2020

Adverse events reported following live, cold-adapted, intranasal influenza vaccine

1 reference

12 December 2020

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells

1 reference

12 December 2020

In vitro and in vivo evaluation of WGA-carbopol modified liposomes as carriers for oral peptide delivery

1 reference

12 December 2020

The preparation and characterization of polymeric antigen delivery systems for oral administration

1 reference

12 December 2020

Flt3 ligand as a vaccine adjuvant in association with HER-2/neu peptide-based vaccines in patients with HER-2/neu-overexpressing cancers

1 reference

12 December 2020

Surface modified liposomes for nasal delivery of DNA vaccine

1 reference

12 December 2020

Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges

1 reference

12 December 2020

Safety and immunogenicity of intranasally administered inactivated trivalent virosome-formulated influenza vaccine containing Escherichia coli heat-labile toxin as a mucosal adjuvant

1 reference

12 December 2020

Nasal lymphoid tissue (NALT) as a mucosal immune inductive site

1 reference

12 December 2020

CpG DNA is an effective oral adjuvant to protein antigens in mice

1 reference

12 December 2020

Lectin binding patterns in rat nasal-associated lymphoid tissue (NALT) and the influence of various types of lectin on particle uptake in NALT

1 reference

12 December 2020

Nasal immune system: distinctive Th0 and Th1/Th2 type environments in murine nasal-associated lymphoid tissues and nasal passage, respectively

1 reference

12 December 2020

Simple synthetic toll-like receptor 2 ligands

1 reference

12 December 2020

Trans-10, cis-12-conjugated linoleic acid attenuates tumor necrosis factor-α production by lipopolysaccharide-stimulated porcine peripheral blood mononuclear cells through induction of interleukin-10

1 reference

12 December 2020

Chitosan as an adjuvant for parenterally administered inactivated influenza vaccines

1 reference

12 December 2020

Evidence of M cells as portals of entry for antigens in the nasopharyngeal lymphoid tissue of humans

1 reference

12 December 2020

10.1007/S13346-012-0085-Z

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

1 reference

PMCID

3539070